KRAS mutated Non‐Small Lung Carcinoma: A Real World Context from the Indian subcontinent

Cancer Medicine(2022)

引用 0|浏览1
暂无评分
摘要
This is the largest single-center experience from the Indian subcontinent for KRAS-mutated NSCLC with distinct clinical features. It highlights the unmet need for G12C inhibitors in our country, where prevalence is equivalent to the West.
更多
查看译文
关键词
G12C,India,KRAS,NSCLC,real-world
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要